Finnegan is an Associate sponsor of the American Conference Institute’s fifth annual biosimilars forum. Finnegan partner Susan Griffen will join the panel discussion “Ethics in the Biosimilars Realm: Avoiding Conflicts and Maintaining Confidentiality in the Brave New World." The program will take place at the InterContinental New York Barclay. For more information, or to register, please see ACI’s website.
Webinar
February 15, 2024
Webinar
Webinar
November 28, 2023
Webinar
Articles
Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation
May 1, 2023
Webinar
February 16, 2022
Webinar
Articles
Patent Trial and Appeal Board Releases Updated Orange Book/Biologic Patent Study
October 20, 2021
IP Health Blog
Update to the Purple Book in Recent COVID-19 Stimulus Bill and Implications for BPCIA Litigation
December 23, 2020
Federal Circuit IP Blog
July 20, 2020
Federal Circuit IP Blog
July 8, 2020
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.